Health technology assessment – joint clinical assessments of medicinal products
EU rules on health technology assessment (Regulation 2021/2282) support cooperation by EU countries to clinically assess new health technologies. The aim is to contribute to a good use of health system resources, while respecting national competences. This initiative concerns joint clinical assessments of medicinal products. It sets out implementing rules to ensure that EU-level assessments of new medicines are conducted in good time and that the relevant experts are involved or consulted.
Read the news announcement published by EC Directorate-General for Health and Food Safety on 5 March 2024.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (21 mai 2024). Health technology assessment – joint clinical assessments of medicinal products. ELSIBI. Consulté le 19 janvier 2025 à l’adresse https://doi.org/10.58079/11ovx
